Product NDC: | 0053-7201 |
Proprietary Name: | Zemaira |
Non Proprietary Name: | alpha-1-proteinase inhibitor human |
Active Ingredient(s): | & nbsp; alpha-1-proteinase inhibitor human |
Administration Route(s): | |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0053-7201 |
Labeler Name: | CSL Behring LLC |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA125078 |
Marketing Category: | BLA |
Start Marketing Date: | 20030708 |
Package NDC: | 0053-7201-02 |
Package Description: | 1 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20) |
NDC Code | 0053-7201-02 |
Proprietary Name | Zemaira |
Package Description | 1 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20) |
Product NDC | 0053-7201 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | alpha-1-proteinase inhibitor human |
Dosage Form Name | KIT |
Route Name | |
Start Marketing Date | 20030708 |
Marketing Category Name | BLA |
Labeler Name | CSL Behring LLC |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |